Regulatory Approval vs Guideline Endorsement of Novel BP-Lowering Treatments

Watchdoq May 21, 2025
This Viewpoint describes the benefits and barriers of conducting cardiovascular disease outcome trials to provide evidence of effectiveness of novel blood pressure (BP)–lowering therapies in reducing hypertension.

Read Full Article